In a previous investigation, we found that AP-1 (together with Sp1) was activated in host cells upon infection with human cytomegalovirus and that a single artesunate treatment suppressed AP-1 activation and production of virus-specific proteins in host cells [34]. The gene discussed is JUND; the disease is infection.